SEARCH

SEARCH BY CITATION

References

  • 1
    Sackett, D. L., Rosenberg, W. M. C., Gray, J. A. M., Haynes, R. B. & Richardson, W. R. (1996) Evidence based medicine: what it is an what it isn't. British Medical Journal, 312, 71.
  • 2
    Gulmezoglu, A. M., Chandler, J., Sheppard, S. & Pantoja, T. (2013) Reviews of qualitative evidence: a new milestone for Cochrane. Cochrane Database of Systematic Reviews, (11), CD000073.
  • 3
    Charlton, B. G. (1997) Restoring the balance: evidence-based medicine put in its place. Journal of Evaluation in Clinical Practice, 3, 8798.
  • 4
    Fricker, M. (2007) Epistemic Injustice: Power and the Ethics of Knowing. New York: Oxford University Press.
  • 5
    Genius, S. J. (2004) Resisting cookbook medicine. British Medical Journal, 329, 179.1.
  • 6
    Moayyedi, P. (2008) CON: evidence-based medicine – the emperor's new clothes? The American Journal of Gastroenterology, 103, 29682969.
  • 7
    Leger-Riopel, N. (2013) Medical liability in an era of evidence-based medicine. Bucerius Law Journal, 2013, 2632. Available at: http://law-journal.de/en/archive/volume-2013/issue-1/medical-liability-in-an-era-of-evidence-based-medicine/ (last accessed 24 June 2014).
  • 8
    McNutt, R. A. & Livingston, E. H. (2010) Evidence-based medicine requires appropriate clinical context. Journal of the American Medical Association, 303, 454455.
  • 9
    Chen, H., Deshpande, A. D., Jiang, R. & Martin, B. C. (2005) An epidemiological investigation of off-label anticonvulsant drug use in the Georgia Medicaid population. Pharmacoepidemiology and Drug Safety, 14, 629639.
  • 10
    Rosner, H., Rubin, L. & Kestenbaum, A. (1996) Gabapentin adjunctive therapy in neuropathic pain states. The Clinical Journal of Pain, 12, 5658.
  • 11
    Backonja, M., Beydoun, A., Edwards, K. R., Schwartz, S. L., Fonesca, V., Hes, M., LaMoreaux, L. & Garofalo, E. (1998) Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. Journal of the American Medical Association, 280, 18311836.
  • 12
    Rowbotham, M., Harden, N., Stacey, B., Bernstein, P. & Magnus-Miller, L. (1998) Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. Journal of the American Medical Association, 280, 18371842.
  • 13
    Wiffen, P., Collins, S., McQuay, H., Carroll, D., Jadad, A. & Moore, A. (2000) Anticonvulsant drugs for acute and chronic pain. Cochrane Database of Systematic Reveiws, (3), CD001133.
  • 14
    Wiffen, P. J., McQuay, H. J., Edwards, J. E. & Moore, R. A. (2005) Gabapentin for acute and chronic pain. Cochrane Database of Systematic Reviews, (3), CD005452.
  • 15
    US Department of Justice (2004) Warner-Lambert to pay $430 million to resolve criminal & civil health care liability relating to off-label promotion. Department of Justice website. Available at: http://www.justice.gov/opa/pr/2004/May/04_civ_322.htm. (last accessed 6 April 2014).
  • 16
    Vedula, S. S., Bero, L. A., Scherer, R. W. & Dickerson, K. (2009) Outcome reporting in industry-sponsored trials of gabapentin for off-label use. New England Journal of Medicine, 361, 19631971.
  • 17
    Chaparro, L. E., Smith, S. A., Moore, R. A., Wiffen, P. J. & Gilron, I. (2013) Pharmacotherapy for the prevention of chronic pain after surgery in adults. Cochrane Database of Systematic Reviews, (7), CD008307.
  • 18
    Therapeutics Initiative (2009) Gabapentin for pain: new evidence from hidden data. Therapeutics Letter, Newsletter #75. Available at: www.ti.ubc.ca/es/letter75 (last accessed 6 April 2014).
  • 19
    Moore, R. A., Wiffen, P. J. & McQuay, H. J. (2011) Gabapentin for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews, (3), CD007938.
  • 20
    Straube, S., Derry, S., Moore, R. A., Wiffen, P. J. & McQuay, H. J. (2010) Single dose oral gabapentin for established acute postoperative pain in adults. Cochrane Database of Systematic Reviews, (5), CD008183.
  • 21
    Lam, W. (2003) Off-label promotion and prescribing of gabapentin. Australian Prescriber, 26, 28.
  • 22
    United States District Court District of Massachusetts (2010) In re Neurontin Marketing and Sales Practices Litigation, Civil Action No. 04-cv-10739-PBS. Available at: http://pacer.mad.uscourts.gov/dc/cgi-bin/recentops.pl?filename=saris/pdf/ucl%20opinion.pdf (last accessed 6 April 2014).
  • 23
    Spence, D. (2013) Bad medicine: gabapentin and pregabalin – response from author. British Medical Journal, 347, f6747.
  • 24
    Health and Social Care Information Centre (2012) Prescription cost analysis England. Available at: https://catalogue.ic.nhs.uk/publications/prescribing/primary/pres-cost-anal-eng-2012/pres-cost-anal-eng-2012a-rep.pdf (last accessed 6 April 2014).
  • 25
    Dworkin, R. H., O'Connor, A. B., Audette, J., et al. (2010) Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clinic Proceedings, 85, S3S14.
  • 26
    Shenfield, G. (2012) Your questions to the PBAC: gabapentin. Australian Prescriber, 36, 82.
  • 27
    Morse, J. M. (1994) ‘Emerging from the data’: The cognitive processes of analysis in qualitative inquiry. In Critical Issues in Qualitative Research Methods (ed. J. M. Morse), pp. 2342. Thousand Oaks: Sage.
  • 28
    Charmaz, K. (2006) Constructing Grounded Theory: A Practical Guide through Qualitative Analysis. London: Sage.
  • 29
    Mercadante, S. (2002) Gabapentin in painful ophthalmoplegia. Journal of Pain Symptom Management, 24, 288289.
  • 30
    Jensen, T. S. & Finnerup, N. B. (2009) Neuropathic pain treatment: a further step forward. Lancet, 374, 12181219.
  • 31
    Klass, M. & Csete, M. (2008) One from column A and one from column B: may I take your order? Anesthesiology, 109, 165166.
  • 32
    Gehling, M. & Tryba, M. (2002) Comment on Rice ASC, Maton S, the Postherpetic Neuralgia Study Group (UK), Gabapentin in postherpetic neuralgia: a randomized, double blind, placebo-controlled study, Pain 2001;94:215–224. Pain, 96, 410411.
  • 33
    Serpell, M. G. & Neuropathic Pain Study Group (2002) Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial. Pain, 99, 557566.
  • 34
    McCleane, G. J. (2003) Comment on: Serpell et al., gabapentin in neuropathic pain syndromes: a randomised double-blind, placebo controlled trial (Pain 2002; 99: 557–66). Pain, 103, 227.
  • 35
    Clendenen, S. R. & Harrison, B. A. (2007) Single-dose gabapentin does not augment postoperative analgesia in ambulatory arthroscopic shoulder surgery. Anesthesia & Analgesia, 105, 280281.
  • 36
    Caraceni, A., Zecca, E., Martini, C. & De Conno, F. (2001) Differences in gabapentin efficacy for cancer pain more apparent than real? Journal of Pain Symptom Management, 21, 9394.
  • 37
    McQuay, H., Carroll, D., Jadad, A. R., Wiffen, P. & Moore, A. (1995) Anticonvulsant drugs for management of pain: a systematic review. British Medical Journal, 311, 10471052.
  • 38
    Adam, F., Sessler, D. I. & Chauvin, M. (2007) Single-dose gabapentin does not augment postoperative analgesia in ambulatory arthroscopic shoulder surgery. Anesthesia & Analgesia, 105, 281.
  • 39
    Buvanendran, A. (2012) Chronic postsurgical pain: are we closer to understanding the puzzle. Anesthesia & Analgesia, 115, 231232.
  • 40
    Kumar, A. & Tyagi, A. (2009) Dixon and Massey's method: the starting dose. Anesthesia & Analgesia, 108, 378.
  • 41
    Ross, J. R., Waight, C., Riley, J. B. & Broadley, K. (2001) Gabapentin: resistant neuropathic pain and malignancy. Palliative Medine, 15, 348349.
  • 42
    Gilron, I. (2003) Gabapentin: a viewpoint by Ian Gilron. CNS Drugs, 17, 983984.
  • 43
    Dubey, P. K. (2008) Gabapentin for the treatment of glossodynia due to an unusual cause. Anesthesia & Analgesia, 107, 729.
  • 44
    Nguyen, V. H. & Lawrence, H. J. (2004) Use of gabapentin in the prevention of taxane-induced arthralgias and myalgias. Journal of Clinical Oncology, 22, 17671769.
  • 45
    van Deventer, H. & Bernard, S. (1999) Use of gabapentin to treat taxane-induced myalgias. Journal of Clinical Oncology, 17, 434435.
  • 46
    Phillips, C. J. (2009) The cost and burden of chronic pain. British Journal of Pain, 3, 25.
  • 47
    Gaskin, D. J. & Richard, P. (2012) The economic costs of pain in the United States. The Journal of Pain, 13, 715724.
  • 48
    Goldberg, D. S. & McGee, S. J. (2011) Pain as a global public health priority. BMC Public Health, 11, 770.
  • 49
    McQuay, H. (2008) Help and hope at the bottom of the pile. British Medical Journal, 336, 954955.
  • 50
    Motov, S. M. & Khan, A. (2009) Problems and barriers of pain management in the emergency department: are we ever going to get better? Journal of Pain Research, 2, 511.
  • 51
    Finnerup, N. B., Otto, M., McQuay, H., Jensen, T. S. & Sindrup, S. H. (2005) Algorithm for neuropathic pain treatment: an evidence based proposal. Pain, 118, 289305.
  • 52
    Ravetz, J. (2004) The post-normal science of precaution. Futures, 36, 347357.
  • 53
    US National Institutes of Health (2014) History, policies, and laws. Clinicaltrials.gov website. Available at: http://www.clinicaltrials.gov/ct2/about-site/history (last accessed 6 April 2014).